AbbVie M21-446 - A Single-Arm Open-Label Study to Evaluate the Efficacy and Safety of ABBV-668 in Subjects With Moderate to Severe Ulcerative Colitis

Brief description of study

The purpose of this study is to see if the study drug called ABBV-668 is safe and effective at treating moderate to severe ulcerative colitis.


Clinical Study Identifier: s22-01178
Principal Investigator: Lev Ginzburg.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.